Medicare Enrolled
Dr. Regina Frants, MD
Pulmonary Disease · Johnson City, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Frants from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Frants?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Frants
Dr. Regina Frants is a pulmonary disease specialist in Johnson City, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Frants performed 762 Medicare services across 613 unique beneficiaries.
Between the years covered by Open Payments, Dr. Frants received a total of $19,491 from 49 pharmaceutical and/or device companies across 918 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Frants is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 49% volume in NY
$19,491 industry payments
Medicare Practice Summary
Medicare Utilization ↗762
Medicare services
Top 49% in NY for pulmonary disease
613
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~38 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
205 | $86 | $141 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
153 | $27 | $128 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
106 | $121 | $195 |
| New patient office visit, complex (60-74 min) | 66 | $150 | $250 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
48 | $91 | $143 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
37 | $56 | $110 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
34 | $25 | $105 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
31 | $163 | $383 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
23 | $41 | $110 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
21 | $32 | $98 |
| Prolonged inpatient or observation care, each additional 15 minutes This code is used for prolonged hospital inpatient or observation care services that extend beyond the total time required for the primary evaluation and management service. It covers each additional 15-minute increment of time spent by the provider. |
20 | $23 | $63 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
18 | $20 | $79 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$19,491
Total received (2018-2024)
Avg $2,784/year across 7 years
Top 11% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
918
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,394 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$97 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,283
2023
$3,513
2022
$3,320
2021
$2,561
2020
$2,235
2019
$2,504
2018
$2,075
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$846
GlaxoSmithKline, LLC.
$549
Mallinckrodt Hospital Products Inc.
$436
Boehringer Ingelheim Pharmaceuticals, Inc.
$397
GENZYME CORPORATION
$203
Baxter Healthcare
$140
FUJIFILM Healthcare Americas Corporation
$122
Electromed, Inc.
$112
Amgen Inc.
$103
Grifols USA, LLC
$79
SANOFI-AVENTIS U.S. LLC
$79
Philips North America LLC
$77
Regeneron Healthcare Solutions, Inc.
$60
Shionogi Inc
$30
Merck Sharp & Dohme LLC
$19
Mylan Specialty L.P.
$17
Insmed, Inc.
$16
Top 3 companies account for 55.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$4,329
GlaxoSmithKline, LLC.
$3,529
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,030
GENZYME CORPORATION
$1,072
Grifols USA, LLC
$902
Regeneron Healthcare Solutions, Inc.
$704
Mallinckrodt Hospital Products Inc.
$581
Janssen Pharmaceuticals, Inc
$546
Electromed, Inc.
$541
Actelion Pharmaceuticals US, Inc.
$490
Genentech USA, Inc.
$460
Novartis Pharmaceuticals Corporation
$326
Merck Sharp & Dohme Corporation
$288
Pulmonx Corporation
$280
Amgen Inc.
$270
Sunovion Pharmaceuticals Inc.
$264
Teva Pharmaceuticals USA, Inc.
$237
Mylan Specialty L.P.
$214
PFIZER INC.
$202
Takeda Pharmaceuticals U.S.A., Inc.
$198
Baxter Healthcare
$197
Philips Electronics North America Corporation
$176
Insmed, Inc.
$151
Allergan Inc.
$150
Melinta Therapeutics, Inc.
$122
FUJIFILM Healthcare Americas Corporation
$122
Allergan, Inc.
$107
ABBVIE INC.
$104
SANOFI-AVENTIS U.S. LLC
$93
Circassia Pharmaceuticals Inc
$90
Philips North America LLC
$77
Mallinckrodt LLC
$71
PORTOLA PHARMACEUTICALS, INC.
$65
Mallinckrodt Enterprises LLC
$60
AbbVie Inc.
$59
Shionogi Inc
$54
Alexion Pharmaceuticals, Inc.
$43
Merck Sharp & Dohme LLC
$39
United Therapeutics Corporation
$39
Bayer HealthCare Pharmaceuticals Inc.
$35
Advanced Respiratory, Inc
$31
Shire North American Group Inc
$31
Olympus America Inc.
$28
Paratek Pharmaceuticals, Inc.
$17
Covis Pharma GmBH
$15
La Jolla Pharmaceutical Company
$15
Gilead Sciences, Inc.
$12
Vapotherm Inc
$12
Acerta Pharma LLC
$11
Top 3 companies account for 50.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (8876) Vest Therapy Und · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ALVESCO · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · CINQAIR · CUTAQUIG · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · ELIQUIS · Esbriet · FASENRA · FUJIFILM · Fetroja · GATTEX · GIAPREZA · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · Hillrom - Vest System Model 105 Home Care · KEYTRUDA · LONHALA MAGNAIR · NUCALA · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENITRAM · Olympus Respiratory Accessories · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · QVAR · SEEBRI NEOHALER · SMARTVEST · SOLIRIS · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · Vabomere · XARELTO · XOLAIR · Xolair · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
9
Per 100K population
4.6
County median income
$61,059
Nearest hospital
OUR LADY OF LOURDES MEMORIAL HOSPITAL, INC
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Frants is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 11% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Frants experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Frants performed 205 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Frants receive payments from pharmaceutical companies?
Yes. Dr. Frants received a total of $19,491 from 49 companies across 918 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Frants's costs compare to other pulmonary diseases in Johnson City?
Dr. Frants's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Frants) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Johnson City
Browse pulmonary diseases in Johnson City ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology